Skip to content

Rüdiger Ilg

Department of Neurology, Klinikum rechts der Isar, Technical University Munich, München, Germany.

4 papers in the library · 142 citations · publishing 2021-2026

Papers

Brain network integration dynamics are associated with loss and recovery of consciousness induced by sevoflurane

Human Brain Mapping March 19, 2021 Andrea I. Luppi, Daniel Golkowski, Andreas Ranft et al. 72 citations

The human brain alternates between states of high integration and segregation, which are thought to support consciousness. Using dynamic functional connectivity and graph theory on resting-state fMRI data from healthy volunteers, the authors show that the integrated state is especially vulnerable to the anaesthetic sevoflurane. At higher doses (3% vol and burst-suppression), anaesthesia reduces the complexity and small-world character of integrated brain states and disrupts the temporal balance between integration and segregation. These effects reverse upon recovery, linking them to consciousness. Reduced anticorrelations between the default mode and executive control networks also reconfigure dynamically depending on the brain's integration state. The breakdown of the integrated sub-state may serve as a generalisable biomarker of loss and recovery of consciousness.

In vivo mapping of pharmacologically induced functional reorganization onto the human brain’s neurotransmitter landscape

Science Advances June 14, 2023 Leor Roseman, Christopher Timmermann, Daniel Golkowski et al. 65 citations

The effects of mind-altering drugs on brain function arise from complex interactions with multiple neurotransmitter systems, not just one. By linking the distribution of 19 neurotransmitter receptors and transporters (measured with PET) to changes in functional connectivity (measured with fMRI) caused by 10 drugs—anesthetics (propofol, sevoflurane, ketamine), psychedelics (LSD, psilocybin, DMT, ayahuasca), and others (MDMA, modafinil, methylphenidate)—the work shows a many-to-many mapping between drug effects and neurotransmitter systems. The drugs' impacts follow hierarchical gradients of brain structure and function, and regional susceptibility to drug-induced changes mirrors susceptibility to structural alterations from brain disorders.

Mapping Pharmacologically-induced Functional Reorganisation onto the Brain’s Neurotransmitter Landscape

bioRxiv (Cold Spring Harbor Laboratory) July 13, 2022 Andrea I. Luppi, Justine Y. Hansen, R. Adapa et al. 5 citations preprint

Psychoactive drugs reshape brain function by engaging multiple neurotransmitter systems simultaneously. By mapping the distribution of 19 neurotransmitter receptors and transporters (via PET) and the connectivity changes caused by 10 drugs (anesthetics, psychedelics, and stimulants), the study shows that drug effects are organized along hierarchical gradients of brain structure and function. Additionally, brain regions susceptible to drug-induced changes are also vulnerable to structural alterations from brain disorders. These findings reveal systematic links between molecular neurochemistry and large-scale functional reorganization.

The blueprint of human functional architecture shifts from cognition to anatomy during perturbations of consciousness

bioRxiv Preprint Server June 7, 2026 Andrea I. Luppi, Dragana Manasova, Justine Y. Hansen et al. preprint

Functional connectivity in the awake human brain is shaped primarily by cognitive co-activation—the tendency of brain regions to work together during mental tasks—more than by structural or molecular constraints. This predominance is systematically lost across five datasets involving pharmacological and pathological perturbations of consciousness (chronic disorders of consciousness; anesthesia with sevoflurane, propofol, or ketamine), when cognition is disconnected from the environment or abolished. During such states, the predictors of functional architecture shift away from cognitive co-activation and toward anatomical and molecular constraints.